European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2004
Relevance of genetically determined host factors to the prognosis of meningococcal disease.
Сравнительное исследованиеСтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Domingo P, Muñiz-Diaz E, Baraldès M A, Arilla M, Barquet N, Pericas R, Juárez C, Madoz P, Vázquez G
Аннотация
To assess the relevance of genetically determined host factors for the prognosis of meningococcal disease, Fc gamma receptor IIA (FcgammaRIIA), the tumor necrosis factor alpha (TNF-alpha) gene promoter region, and plasminogen-activator-inhibitor-1 (PAI-1) gene polymorphisms were studied in 145 patients with meningococcal disease and in 290 healthy controls matched by sex. Distribution of FcgammaRIIA, TNF-alpha, and PAI-1 alleles was not significantly different between patients and controls. Patients with the FcgammaRIIA-R/R 131 allotype scored > or =1 point in the Barcelona prognostic system more frequently than patients with other allotypes (odds ratio, 18.6; 95% confidence interval, 7.1-49.0, P<0.0001), and they had a higher risk of sequelae (odds ratio, 3.5; 95% confidence interval, 1.1-11.7; P=0.03). Fc gamma receptor IIA polymorphism was associated with markers of disease severity, but TNF-alpha and PAI-1 polymorphisms were not.
Предметные рубрики MeSH
AdolescentAdultAntigens, CDCase-Control StudiesChildChild, PreschoolConfidence IntervalsFemaleGenetic MarkersGenetic Predisposition to DiseaseHumansIncidenceMaleMeningococcal InfectionsOdds RatioPlasminogen Activator Inhibitor 1Polymorphism, GeneticProbabilityPrognosisPromoter Regions, GeneticReceptors, IgGSensitivity and SpecificitySeverity of Illness IndexSpainTumor Necrosis Factor-alpha